Page last updated: 2024-10-22

am 251 and Glaucoma, Suspect

am 251 has been researched along with Glaucoma, Suspect in 1 studies

AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.

Research Excerpts

ExcerptRelevanceReference
"Mean intraocular pressure was increased up to 88."1.39Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat. ( Pinar-Sueiro, S; Sharma, SC; Vecino, E; Veiga-Crespo, P; Zorrilla Hurtado, JÁ, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pinar-Sueiro, S1
Zorrilla Hurtado, JÁ1
Veiga-Crespo, P1
Sharma, SC1
Vecino, E1

Other Studies

1 other study available for am 251 and Glaucoma, Suspect

ArticleYear
Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat.
    Experimental eye research, 2013, Volume: 110

    Topics: Administration, Topical; Animals; Benzoxazines; Cell Count; Disease Models, Animal; Female; Intraocu

2013